Navigation Links
New Antibiotic Could Shorten TB Treatment
Date:4/2/2009

Less time to completion may boost patient compliance, outcomes, researchers say

THURSDAY, April 2 (HealthDay News) -- Using a new antibiotic called moxifloxacin in combination with other drugs could cut several months off the six months it currently takes to cure patients with drug-treatable tuberculosis, according to a phase 2 study.

Long treatment times can result in patients failing to complete their drug therapy, so a shorter period of treatment could improve patient compliance, the researchers noted. Shorter TB treatment regimens would also reduce the workload for overburdened TB control programs, especially in countries with high TB rates.

The study included 170 TB patients treated at a hospital in Rio de Janeiro, Brazil, who were receiving a standard combination of three first-line TB drugs. They were randomly selected to receive as their fourth drug either moxifloxacin 400 milligrams, along with an ethambutol placebo (85 patients), or ethambutol (15-20 mg per kilogram of body weight) plus moxifloxacin placebo (85 patients) five days a week for eight weeks.

The drug ethambutol is widely used in TB treatment but has very little activity and was used as a control in this study.

After eight weeks, 80 percent of patients in the moxifloxacin group tested negative for TB, compared with 63 percent of patients in the ethambutol group. A total of 16 negative events (eight in each group) were reported in 12 patients, but only one of those events was linked to moxifloxacin, according to Dr. Richard E. Chaisson, of the Center for Tuberculosis Research at Johns Hopkins University School of Medicine in Baltimore, and colleagues.

The study is in the April 4 edition of The Lancet.

"The results of our trial have substantial implications for future trials. First, the improved culture conversion rate found after 8 weeks in the experimental group suggest that moxifloxacin, in combination with other first-line anti-tuberculosis drugs, could shorten the time needed to cure tuberculosis by several months," the research team wrote.

More information

The American Lung Association has more about tuberculosis.



-- Robert Preidt



SOURCE: The Lancet, news release, April 2, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Giant Food Extends Its Free Antibiotic Prescription Program Through July 11, 2009
2. Rep. Slaughter Reintroduces Bill to Help Fight Antibiotic Resistance Crisis by Combating Misuse of Antibiotics in Animal Agriculture
3. Pew Applauds Introduction of Preservation of Antibiotics for Medical Treatment Act
4. AUDIO from Medialink and Ortho-McNeil-Janssen Pharmaceuticals: Risks of Overusing Antibiotics
5. A Broad-Spectrum Antibiotic with Activity Against MRSA and Pseudomonas Aeruginosa Would Earn a Higher Patient Share in the U.S. than in Europe for the Treatment of Hospital-Acquired Pneumonia
6. Antibiotic Combo Fights Resistant TB
7. Arbor Pharmaceuticals Announces the Launch of XYLAREX(TM) - A New Nonantibiotic Product for the Dietary Management of Recurrent Ear Infections in Children
8. Antibiotic-Resistant Meningitis Reported in U.S.
9. Health experts urge supermarket pharmacies to get smart about free antibiotics
10. Activity Against Drug-Resistant Pathogens is One of the Leading Attributes Influencing Physicians Antibiotic Selection for the Treatment of Inpatient Community-Acquired Pneumonia
11. Could carbon dioxide replace antibiotics in surgery?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Antibiotic Could Shorten TB Treatment
(Date:3/24/2017)... Orion, MI (PRWEB) , ... March 24, 2017 ... ... insurance assistance, financial planning, and related services to families and business owners across ... initiative aimed at feeding regional families struggling with financial difficulties. , The Oxford/Orion ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... that they are now offering treatments for sleep apnea and TMJ at their ... Sleep apnea , specifically the obstructive type, is increasingly being treated at ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ( ... patients for colonoscopy at the HyGIeaCare® Center that is to be located adjacent ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug Administration ...
(Date:3/24/2017)... ... ... “End Time GPS”: a dauntless and enlightened study of the second-coming ... the creation of published author, Wesley Gerboth, a World War II veteran, with a ... Now, at age ninety-one, he shares the Wisdom God bestowed upon him in this ...
(Date:3/23/2017)... , ... March 23, 2017 , ... In 2016 the ... estimates that there could be four million Zika-related cases in the Americas within the ... numbers of US cases reported per year skyrocketing to an estimated 329,000. Yet, Zika, ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... -- Transportation Insight, a multi-modal lead logistics solutions provider receives ... with expertise serving clients in the food industry. Vice ... was named a 2017 Food Logistics Champion: ... publication exclusively dedicated to covering the movement of product ... has brought to Transportation Insight a wealth of knowledge ...
(Date:3/23/2017)... Calif. and INDIANAPOLIS , ... LLY ) and the William Sansum Diabetes ... lives of Latino people affected by diabetes through enhanced ... burden of diabetes and cardiovascular disease bears a disproportionate ... States ," said David Kerr , M.D., ...
(Date:3/23/2017)... , March 23, 2017  The U.S. Food and ... for the treatment of adults and pediatric patients 12 ... including those who have not received prior chemotherapy. This ... rare, aggressive form of skin cancer. "While ... patients with a rare form called Merkel cell cancer ...
Breaking Medicine Technology: